PHT Expands eClinical Trial Presence in Asia-Pacific by Partnering with Mebix, Inc.
Mebix to provide Sales, Study Support and Project Management in Japan
CHARLESTOWN, MA – April 10, 2007 – In 2005, PHT became the first electronic patient reported outcome (ePRO) provider to conduct a clinical trial using electronic patient diaries in Japan. Since then, Japanese sponsors have been able to take advantage of the benefits of PHT’s market-leading LogPad® System, which has been selected for use in over 275 trials worldwide. Today, PHT is excited to announce its partnership with Mebix, Inc., the leading provider of evidence based medicine monitoring solutions in Japan, to further enhance and advance the ePRO experience for Japanese biopharmaceutical companies. With Mebix providing expert localized Sales, Study Support and Project Management services, PHT is strengthening its position as the ePRO vendor of choice in the Asia-Pacific region.“Mebix has a well-established reputation for being the gold standard in Japan for managing multi-center, large-scale clinical trials and studies conducted by academic institutes, research organizations and physicians to evaluate the efficacy and safety of their pharmaceuticals,” said Phil Lee, PHT President and CEO. “We see a natural partnership between our two companies, as we are both focused on using our respective innovative technologies to improve data quality and streamline clinical trial management.”
Mebix’s CapTool trial support management system, developed in cooperation with the University of Tokyo, was designed to collect and manage high-quality data efficiently and at a lower cost compared to paper and human-based data collection methods. Mebix also offers comprehensive study protocol planning, data management, statistical analysis and other services to support large-scale clinical studies.
About Mebix, Inc.
Mebix. Inc. provides the efficient, high-quality, and cost-effective data collecting/managing system for clinical trials by employing the state-of-the-art IT technologies. Mebix. Inc. also provides broad range of clinical support services to ensure the clinical trials to be reliable.
About PHT Corporation
PHT is the market-leading provider of electronic patient reported outcome (ePRO) solutions used in more than 275 clinical trials around the world. Our proven LogPad® and StudyPad® Systems deliver the voice of the patient – directly and without distortion – with reliable and timely self-reported data. By capturing more and better PRO data with reduced variance, sponsors are able to conduct smaller, faster clinical trials. Meanwhile, StudyWorks™ helps sites improve trial management efficiencies with real-time access to symptom, compliance and enrollment data.
PHT’s exclusive products and features include wirelessly integrated eSense™ Sensors, real-time calculations and scoring, email safety alerts, and the mobile SimpleSend™ Wireless Pak™, which provides traditional Palm devices with global wireless data transmission capabilities. Patient data captured firsthand by PHT’s ePRO systems have been used successfully in at least eight NDA submissions, with five known approvals, to date. With the PHT Product Suite, biopharmaceutical and medical device companies have more control over their clinical studies and can investigate innovative new areas of scientific research – ultimately resulting in more successful trials. Learn how leading companies worldwide use and benefit from PHT’s ePRO solutions at the new www.phtcorp.com.
###
